Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II tria...

od Orlando, Laura, Lorusso, Vito, Giotta, Francesco, Di Maio, Massimo, Schiavone, Paola, Fedele, Palma, Quaranta, Annamaria, Caliolo, Chiara, Ciccarese, Mariangela, Cinefra, Margherita, Romito, Sante, Pisconti, Salvatore, Prete, Salvatore del, Aieta, Michele, Rizzi, Daniele, Maiello, Evaristo, Colucci, Giuseppe, Cinieri, Saverio
Izdano u Breast (2020)

Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience

od Lutrino, Eufemia S., Orlando, Laura, Febbraro, Antonio, Giampaglia, Marianna, Zamagni, Claudio, Schiavone, Paola, Scavelli, Claudio, Dima, Gianluca, Fedele, Palma, Giordano, Guido, Bilancia, Domenico, Quaranta, Anna Maria, Rubino, Daniela, Filippelli, Gianfranco, Fontanella, Caterina, Caliolo, Chiara, Marino, Antonella, Calvani, Nicola, Ferrara, Pasqualinda, Cinieri, Saverio
Izdano u Tumori (2019)

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (It...

od Leo, Silvana, Arnoldi, Ermenegildo, Repetto, Lazzaro, Coccorullo, Zaira, Cinieri, Saverio, Fedele, Palma, Cazzaniga, Marina, Lorusso, Vito, Latorre, Agnese, Campanella, Giovanna, Ciccarese, Mariangela, Accettura, Caterina, Pisconti, Salvatore, Rinaldi, Antonio, Brunetti, Cosimo, Raffaele, Mimma, Coltelli, Luigi, Spazzapan, Salvatore, Fratino, Lucia, Petrucelli, Luciana, Biganzoli, Laura
Izdano u Oncologist (2018)